Biome Australia – Company presentation April 2024
Biome Business Opportunity
- Novel range of Live Biotherapeutics with co-prescribing medication opportunity
- Landmark IP Deal executed on novel probiotic strains
- Three ongoing clinical trials on key products
- International Expansion — UK, Irish health retail market launch to support existing HCP market
- Delivering $50,000+ per sqm gross margin return on floor space in top accounts
- Over 5,000 distribution points (Aus) following successful launch with Priceline Pharmacy
- Average shopper — 2.1 units per transaction and 6 visits per year in pharmacy (TerryWhite)
- #1 Professional Probiotic brand in Australian Healthcare Practitioner (HCP) Market
- Activated Probiotics #1 brand for growth in TerryWhite and Priceline Pharmacy
- Activated Probiotics #1 brand for growth with Symbion, API Wholesale and entire pharmacy market (VMS)